Biofrontera Valuation
| BFRI Stock | USD 0.89 0.03 3.49% |
Today, the firm appears to be undervalued. Biofrontera shows a prevailing Real Value of $2.12 per share. The current price of the firm is $0.89. Our model approximates the value of Biofrontera from analyzing the firm fundamentals such as Profit Margin of (0.47) %, current valuation of 10.55 M, and Return On Equity of -11.92 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Biofrontera's price fluctuation is dangerous at this time. Calculation of the real value of Biofrontera is based on 3 months time horizon. Increasing Biofrontera's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biofrontera is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biofrontera Stock. However, Biofrontera's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.89 | Real 2.12 | Hype 0.91 | Naive 0.97 |
The intrinsic value of Biofrontera's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Biofrontera's stock price.
Estimating the potential upside or downside of Biofrontera helps investors to forecast how Biofrontera stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biofrontera more accurately as focusing exclusively on Biofrontera's fundamentals will not take into account other important factors: About Biofrontera Valuation
An absolute valuation paradigm, as applied to Biofrontera Stock, attempts to find the value of Biofrontera based on its fundamental and basic technical indicators. By analyzing Biofrontera's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biofrontera's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biofrontera. We calculate exposure to Biofrontera's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biofrontera's related companies.Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Biofrontera operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.
Biofrontera Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 5.5 M | |
| Forward Price Earnings | 12.9702 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |